In vitro activity of Biapenem plus RPX7009, a carbapenem combined with a serine β-lactamase inhibitor, against anaerobic bacteria.
about
New β-Lactamase Inhibitors in the ClinicNew β-lactamase inhibitors: a therapeutic renaissance in an MDR world.Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens.Clinical and microbiological characteristics of Eggerthella lenta bacteremiaNovel β-lactamase inhibitors: a therapeutic hope against the scourge of multidrug resistanceEggerthella lenta bacteremia complicated by spondylodiscitis, psoas abscess, and meningitis.Fragment-based inhibitor discovery against β-lactamaseβ-lactam/β-lactamase inhibitor combinations: from then to now.New promising β-lactamase inhibitors for clinical use.Recent developments in antibiotic agents for the treatment of complicated intra-abdominal infections.Recent Advances in the Rational Design and Optimization of Antibacterial Agents.Optimal Treatment for Complicated Intra-abdominal Infections in the Era of Antibiotic Resistance: A Systematic Review and Meta-Analysis of the Efficacy and Safety of Combined Therapy With MetronidazoleNovel Beta-Lactamase Inhibitors: Unlocking Their Potential in Therapy.Interactions of "bora-penicilloates" with serine β-lactamases and DD-peptidasesImipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.Meropenem-vaborbactam: a new weapon in the war against infections due to resistant Gram-negative bacteria.First Penicillin-Binding Protein Occupancy Patterns of β-Lactams and β-Lactamase Inhibitors in Klebsiella pneumoniaeCovalent docking of selected boron-based serine beta-lactamase inhibitorsDiversity and Proliferation of Metallo-β-Lactamases: a Clarion Call for Clinically Effective Metallo-β-Lactamase Inhibitors
P2860
Q26747150-BB6124F3-137E-4BCC-9D1D-CDC70729CF85Q33622976-E949A2CA-E69D-47A1-8A62-1151EEE5D02DQ34447679-FE714341-CB21-4E8F-979B-EB04C270E6FBQ34983043-5C7ADC26-D62F-4BF3-8E9F-1CCE7162B148Q37411475-AEE2E8FB-3F57-4FCA-92C4-F7E5E2945C87Q37713440-2A37FE2F-1AF1-4BC6-82CE-069228F0ABFDQ38196443-D6949FFC-7E37-4DB4-AC8D-E439C3EE72A8Q38264182-43535467-F3BE-4B13-91E3-5ED6605A5BA1Q38416383-5A48D66D-FE74-4F5E-88CC-1B2773289208Q38648594-ED516082-BB2D-4C77-A8B7-CFA34F79016EQ38958278-1AB98D03-E05F-4C17-818A-3520DCB7A76CQ38972381-BF5F60D3-43D9-4E06-A6B0-17E9AD37E543Q39183212-B03298F2-9DC5-4827-8F16-730413F2CD6CQ42173413-FB1AD046-BD00-4E67-A380-0775E702263BQ46243175-009FCE69-FAC3-435A-864A-D1B2E6403F00Q52564980-0B234F3E-AAAA-421C-AE2F-2DD92574AADBQ57240386-7500E532-2CBF-4717-9973-862F639C4D68Q57794478-4CFFFB63-181B-40A7-B801-4050EF70C3BCQ58641878-0ABC844D-67A4-4508-88BF-6B69F6A398D9
P2860
In vitro activity of Biapenem plus RPX7009, a carbapenem combined with a serine β-lactamase inhibitor, against anaerobic bacteria.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
In vitro activity of Biapenem ...... r, against anaerobic bacteria.
@en
In vitro activity of Biapenem ...... r, against anaerobic bacteria.
@nl
type
label
In vitro activity of Biapenem ...... r, against anaerobic bacteria.
@en
In vitro activity of Biapenem ...... r, against anaerobic bacteria.
@nl
prefLabel
In vitro activity of Biapenem ...... r, against anaerobic bacteria.
@en
In vitro activity of Biapenem ...... r, against anaerobic bacteria.
@nl
P2093
P2860
P356
P1476
In vitro activity of Biapenem ...... r, against anaerobic bacteria.
@en
P2093
C Vreni Merriam
Diane M Citron
Ellie J C Goldstein
Kerin L Tyrrell
P2860
P304
P356
10.1128/AAC.02418-12
P407
P577
2013-03-25T00:00:00Z